Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
3.460
-0.190 (-5.21%)
Feb 21, 2025, 4:00 PM EST - Market closed
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $125.39 million as of February 21, 2025. Its market cap has decreased by -81.19% in one year.
Market Cap
125.39M
Enterprise Value
47.00M
1-Year Change
-81.19%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $125.39M, a decrease of -74.36%. That is a compound annual growth rate of -29.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 125.39M | -10.82% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.61B |
| UnitedHealth Group | 463.31B |
| Johnson & Johnson | 383.47B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.35B |
| Abbott Laboratories | 230.32B |
| AstraZeneca | 227.07B |
| Merck & Co. | 219.72B |